False
By Timothy Pas, Laure Descamps
July 27, 2026
AI can help formulation teams better predict performance and allocate resources, but proprietary data protections remain a critical bottleneck
3 min read
July 21, 2026
John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines
4 min read
By Ying K. Tam, Sean Semple
July 13, 2026
How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments
6 min read
June 30, 2026
A special collection of recent stories exploring oral dose innovation, API stability, nitrosamine testing, and the evolving science of small molecule medicines
1 min read
By Matthew Weinberg
April 15, 2026
How to turn regulatory complexity into strategic strength
7 min read
March 3, 2026
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
4 min read
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
February 18, 2026
Regulatory filing for Arexvy has been accepted for review in China for adults aged 60 and older, where RSV affects millions each year
2 min read
February 13, 2026
Twin-screw extrusion’s role in enabling precise, scalable pharmaceutical manufacturing
7 min read
By Achim Link
January 28, 2026
GLP-1 peptides validated the science. CMC will validate the small molecule modality for GLP-1 efficacy, scalability, and access.
4 min read
False